Simple model for the study of Pseudomonas aeruginosa infections in leukopenic mice
暂无分享,去创建一个
[1] I. A. Holder,et al. Flagellar preparations from Pseudomonas aeruginosa: animal protection studies , 1982, Infection and immunity.
[2] E. Ziegler,et al. Pseudomonas aeruginosa vasculitis and bacteremia following conjunctivitis: a simple model of fatal pseudomonas infection in neutropenia. , 1979, The Journal of infectious diseases.
[3] R. Doggett,et al. Pseudomonas aeruginosa : clinical manifestations of infection and current therapy , 1979 .
[4] G. Pier,et al. Protective immunity induced in mice by immunization with high-molecular-weight polysaccharide from Pseudomonas aeruginosa , 1978, Infection and immunity.
[5] B. Wretlind,et al. Experimental infections with protease-deficient mutants of Pseudomonas aeruginosa in mice. , 1978, Journal of medical microbiology.
[6] I. A. Holder,et al. Role of Exotoxin and Protease as Possible Virulence Factors in Experimental Infections with Pseudomonas aeruginosa , 1978, Infection and immunity.
[7] M. Pollack,et al. Passive protection by antitoxin in experimental Pseudomonas aeruginosa burn infections , 1977, Infection and immunity.
[8] L. Hazlett,et al. Pseudomonas eye infections in cyclophosphamide-treated mice. , 1977, Investigative ophthalmology & visual science.
[9] B. Andersen,et al. Passive immunity against pseudomonas sepsis during granulocytopenia , 1976, Infection and immunity.
[10] B. Andersen,et al. Evaluation of type-specific and non-type-specific pseudomonas vaccine for treatment of pseudomonas sepsis during granulocytopenia , 1976, Infection and immunity.
[11] J. Grogan. Pseudomonas aeruginosa infection in mice after treatment with cyclophosphamide. , 1975, Archives of surgery.
[12] J. Pennington,et al. Use of a Pseudomonas Aeruginosa vaccine in pateints with acute leukemia and cystic fibrosis. , 1975, The American journal of medicine.
[13] D. Armstrong,et al. Bacteremia due to Pseudomonas aeruginosa complicating neoplastic disease: a progress report. , 1974, The Journal of infectious diseases.
[14] P. Wiernik,et al. Significance of Pseudomonas aeruginosa in the patient with leukemia or lymphoma. , 1974, The Journal of infectious diseases.
[15] B. Andersen,et al. Pseudomonas Septicemia in Neutropenic Dogs I. Treatment with Granulocyte Transfusions , 1974, Transfusion.
[16] D. Armstrong,et al. Controlled prospective trial of Pseudomonas aeruginosa vaccine in children with acute leukemia , 1973, Cancer.
[17] L. Young,et al. Pseudomonas aeruginosa vaccine in cancer patients. , 1973, Annals of internal medicine.
[18] L. Young,et al. Pseudomonas aeruginosa infections. , 2008, CRC critical reviews in clinical laboratory sciences.
[19] L. Reed,et al. A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS , 1938 .